holdings
announce
third
quarter
financial
results
november
houston
globe
newswire
holdings
nasdaq
bpth
biotechnology
company
leveraging
proprietary
antisense
rnai
nanoparticle
technology
develop
portfolio
targeted
nucleic
acid
cancer
drugs
today
announced
host
live
conference
call
audio
webcast
friday
november
et
report
financial
results
third
quarter
ended
september
provide
business
overview
access
live
conference
call
please
call
domestic
international
least
five
minutes
prior
start
time
refer
conference
id
live
audio
webcast
call
also
available
presentations
section
company
website
archived
webcast
available
website
approximately
two
hours
event
holdings
biotechnology
company
developing
novel
technology
yielded
pipeline
rnai
nanoparticle
drugs
administered
simple
intravenous
transfusion
lead
product
candidate
prexigebersen
targeting
protein
phase
study
blood
cancers
drug
product
modification
prexigebersen
consideration
fda
commence
phase
studies
solid
tumors
followed
targeting
protein
evaluated
lymphoma
solid
tumors
clinical
studies
information
please
visit
company
website
http
contact
information
investors
connor
stern
investor
relations
doug
morris
investor
relations
holdings
